Announcing New Partners in Georgia Life Sciences Cost Savings Program

We are excited to welcome several new strategic partners to the Georgia Life Sciences Cost Savings Program. These partnerships are designed to help Georgia-based life sciences companies optimize costs, increase efficiency, and enhance business operations.

The new partners will offer life sciences businesses exclusive savings on products and services ranging from laboratory supplies to essential business services, ensuring companies can focus more on innovation and growth.

 

The new partners joining the program include:

  1. Biotech Exec - Executive Staffing and Management Consulting
  2. Corporate Traveler - Business Travel Management Services
  3. NexGen BioBanking - Biospecimen Storage and Supply Solutions
  4. Select Gases - Specialty, Medical, and Industrial Gases
  5. SU Group - Equipment Maintenance Management Program (EMMP)

 

These partnerships bring added value to Georgia’s thriving life sciences ecosystem by providing essential resources to companies at every stage of development. From startups to established industry leaders, these new cost-saving opportunities will help foster continued growth for Georgia Life Science members. To learn more about our portfolio of cost savings partnerships and specific discounts, visit www.galifesciences.org/membership/savings-portfolio.

September 11, 2025
Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.
By Maria Thacker Goethe September 5, 2025
Protecting U.S. Leadership in Agricultural Biotechnology
By Maria Thacker Goethe August 29, 2025
Celebrating the Next Generation of Scientific Breakthroughs in Georgia
MORE POSTS